Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

Clinical trial NCT00163514 · COMPLETED

Trial details

NCT number: NCT00163514
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Perennial Allergic Rhinitis Allergic Rhinitis Hay Fever

Start date: 2004-05-01
Primary completion: 2005-07-01
Enrollment: 636

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.